Mariëtte E G Kranendonk

6PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 14, 2026
Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

|Jan 06, 2026
De novo H3.3K27M-altered diffuse midline glioma in human brainstem organoids to dissect GD2 CAR T cell function.

Nils Bessler, Amber K L Wezenaar, Hendrikus C R Ariese

|Jul 29, 2025
Multimodal analysis of pediatric pilocytic astrocytomas reveals tumor location-associated cellular and transcriptional heterogeneity.

Julie A S Lammers, Jacob S Rozowsky, Friso G Calkoen

|Apr 10, 2025
Do we need B7-H3 immunohistochemistry for the inclusion of children with high-grade central nervous system tumors in clinical trials targeting B7-H3?

Mariëtte E G Kranendonk, Raoull Hoogendijk, Julie A S Lammers

|Oct 11, 2023
Ultra-fast deep-learned CNS tumour classification during surgery.

C Vermeulen, M Pagès-Gallego, L Kester

|Jul 27, 2020
The decisive role of molecular pathology in presumed somatic metastases of type II testicular germ cell tumors: report of 2 cases.

Mariëtte E G Kranendonk, Wenzel M Hackeng, G Johan A Offerhaus

Pageof 1

Frequent Collaborators

1 joint publications

C Vermeulen

1 joint publications

M Pagès-Gallego

1 joint publications

P de Witt Hamer

1 joint publications

J van der Lugt